SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
For Immediate Release
August, 18 2016, 12:45pm EDT
Contact:
press@sanders.senate.gov
Sanders Applauds Decision to End Federal Use of Private Prisons
U.S. Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday after the Justice Department announced plans to end its use of private prisons:
"Our criminal justice system is broken and in need of major reforms. The Justice Department's plan to end its use of private prisons is an important step in the right direction. It is exactly what I campaigned on as a candidate for president.
WASHINGTON
U.S. Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday after the Justice Department announced plans to end its use of private prisons:
"Our criminal justice system is broken and in need of major reforms. The Justice Department's plan to end its use of private prisons is an important step in the right direction. It is exactly what I campaigned on as a candidate for president.
"It is an international embarrassment that we put more people behind bars than any other country on earth. Due in large part to private prisons, incarceration has been a source of major profits to private corporations. Study after study after study has shown private prisons are not cheaper, they are not safer, and they do not provide better outcomes for either the prisoners or the state.
"We have got to end the private prison racket in America as quickly as possible. Our focus should be on keeping people out of jail and making sure they stay out when they are released. This means funding jobs and education not more jails and incarceration."
Sanders introduced legislation last year with Reps. Raul M. Grijalva (D-Ariz.), Keith Ellison (D-Minn.) and Bobby L. Rush (D-Ill.) to ban private prisons
LATEST NEWS
Demonstrators Rally in Milan to Say 'FCK ICE' as Winter Olympics Kick Off
One Olympic athlete, a skier representing Britain, registered his disgust with US immigration enforcement agents by urinating the message "Fuck ICE" in the snow.
Feb 06, 2026
Hundreds of protesters gathered in the streets of Milan, Italy on Friday to protest the presence of US Immigration and Customs Enforcement agents at the 2026 Winter Olympics, with protesters waving "FCK ICE" signs and condemning Trump administration officials—including Vice President JD Vance and Secretary of State Marco Rubio.
Reuters reported that demonstrators rallying ahead of the opening ceremony could be heard "blowing plastic whistles, which have become a symbol of anti-ICE rallies in the US." The Trump administration said a small group of ICE officers would be traveling to Milan to help provide security for Vance and Rubio, who arrived in the city on Thursday.
One demonstrator, a Minnesotan currently studying in Europe, told the outlet that she "thought that this was a good opportunity to show that the rest of the world is not okay with what's happening in Minnesota."
"It's not okay to just acquiesce and go with the status quo," the protester said.
Demonstrators take part in a protest against US Immigration and Customs Enforcement in Milan, Italy on February 6, 2026. (Photo by Mattia Rinaldi/NurPhoto via Getty Images)
The protests came a day after Gus Kenworthy, a skier representing Britain, urinated the message "Fuck ICE" in the snow ahead of the winter games' opening festivities and urged Americans to pressure their representatives to rein in the agency.
"Innocent people have been murdered, and enough is enough," Kenworthy wrote on social media. "We can’t wait around while ICE continues to operate with unchecked power."
Keep ReadingShow Less
Gallego Says ‘Grind the Country to a Halt’ With National Strike If Trump Tries to Rig Midterms
"If you take away our democratic stability, we will take away the economic stability."
Feb 06, 2026
A centrist Democratic US senator is now talking about taking drastic measures to protect democracy from President Donald Trump.
Speaking with the Court of History podcast on Thursday, Sen. Ruben Gallego (D-Ariz.) outlined a plan to stop Trump in case he tries to follow through on his threat to "nationalize the vote" ahead of the 2026 midterm elections or if he tried to enact ally Steve Bannon's proposal to "surround the polls" with US Immigration and Custom Enforcement (ICE) agents.
"We have to prepare for the outmost scenario, the worst scenario," said Gallego, "which is they try to either capture the ballot box as ballots are being counted, they try to stop the count, they try to surround polling places, whatever it is."
Getting more specific, Gallego said that something like a general strike along the lines of the one that took place in Minneapolis last month to protest ICE deployment in the city would be justified.
"We need to make sure that we have an ultimate response to that which, I believe, has to be a true national strike," he said, "in the sense that, if they do this, if they try to overthrow our democracy, if you are allied with democracy, do not go to work. If you’re a pilot, do not show up. If you drive a train, do not show up. If you’re a teacher, do not show up. We grind the country to a halt."
Gallego acknowledged the damage that this would do to the US economy, but said that "if we have to destroy the stock market to save democracy, we need to accept that."
He also said such an action would send an unmistakeable message to the billionaires who have given Trump their full-throated backing during his second term.
"The richest and the most powerful people in the world and in this country need to understand that that is a real possibility," he emphasized. "There is no economic stability without democratic stability. If you take away our democratic stability, we will take away the economic stability."
Gallego isn't alone in saying that concrete steps may have to be taken to protect US democracy from the president this year.
Elections expert Rick Hasen, a law professor at the University of California, said in an interview published by the New Republic on Friday that both state and city governments, as well as individual citizens, may be needed to ensure the integrity of the 2026 midterms.
"I think states and local governments need to be prepared for this," he said. "I would suggest trying to get injunctions against the federal government to keep them away. I would suggest that lawyers for voting rights groups and Democrats be prepared to go to court."
Failing that, he said that citizens must be prepared to get involved on the ground.
"I mean, it may take people in the streets protecting the offices where ballots are being tabulated," he said. "To take the Brooks Brothers riot—from the 2000 disputed election where some people were trying to storm an office where they were recounting ballots in Bush v. Gore—that would look very tame compared to what, you know, we might see in 2026."
Keep ReadingShow Less
TrumpRx Denounced as Corrupt Scheme to Line Pockets of Big Pharma—and Don Jr.
"Trump has dressed up yet another corporate giveaway as a boon to patients," said one watchdog. "Real drug price reform doesn’t look like a website."
Feb 06, 2026
US President Donald Trump on Thursday launched a website, branded with his name, in a purported effort to help patients buy prescription drugs at lower prices.
But experts, watchdog groups, and Democratic lawmakers said TrumpRx will likely do little for consumers—or for the broader goal of bringing down exorbitant medicine costs—while further enriching Big Pharma and potentially lining the pockets of his eldest son, Donald Trump Jr.
TrumpRx.gov, launched in partnership with pharmaceutical giants, points users to direct-to-patient sales platforms hosted by drug companies to facilitate the purchase of an extremely limited selection of medications. For example, TrumpRx's listing for Farxiga links users to AstraZeneca Direct, where patients can pay out of pocket for the type 2 diabetes medication.
Donald Trump Jr. is on the board of BlinkRx, a prescription drug platform that stands to benefit from the Trump administration's promotion of direct-to-patient medicine sales. In December, the president's son reportedly met with top drug company executives and administration officials responsible for regulating the pharmaceutical industry—a gathering hosted by BlinkRx.
Frank Pallone Jr. (D-NJ), the top Democrat on the House Energy and Commerce Committee, said in a statement Thursday that TrumpRx "not only threatens patients’ health, safety, and privacy, but also likely includes kickback schemes designed to enrich President Trump, his family, and their friends."
"TrumpRx has been shrouded in secrecy from the beginning because the administration clearly does not want anyone to know it likely won’t save patients money," said Pallone. "However, we do know Trump only slaps his name on things when there’s something in it for him."
Last week, a group of Democratic senators sent a letter to the inspector general of the US Department of Health and Human Services warning that "without stricter safeguards before its official launch, TrumpRx could be used as a potential vehicle for unlawful kickback schemes that result in excessive costs for the federal government."
In addition to sending users to direct-to-patient sales sites, TrumpRx offers Trump-branded coupons for some medications. To obtain a coupon, site users must accept terms that state: "You agree that by redeeming this coupon, you (and anyone else acting on your behalf) agree not to seek reimbursement from any insurance plan for out-of-pocket costs for prescriptions purchased with this coupon. You also agree not to count the cost of prescriptions toward your deductible or true out-of-pocket costs."
The Washington Post reported that pharmaceutical companies "have agreed to list their drugs on TrumpRx.gov."
"TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
Experts warned that patients who use TrumpRx could end up paying more for their medications than if they pursued other available options.
"TrumpRx’s offerings are very limited, fewer than 50 drugs listed, and most are niche products used by few patients," Rena Conti, an associate professor at Boston University, told ABC News. "Many are available in generic form at even lower prices or already available to consumers at low or even very low prices elsewhere. This suggests it pays for consumers to check their insurance coverage and ask their regular doctor or pharmacist before they use this service."
Peter Maybarduk, access to medicines director at Public Citizen, offered a more scathing assessment of TrumpRx, saying the president has "dressed up yet another corporate giveaway as a boon to patients."
"Most patients will do better through their insurance than through TrumpRx. Many patients without insurance will not be able to afford drugmakers’ still-high prices funneled through TrumpRx," said Maybarduk. "But drugmakers certainly will appreciate TrumpRx’s free promotion of their products, delivered with a false veneer of price accountability. TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
“TrumpRx also appears to be another example of this president’s repeated corruption," he continued. "Trump’s son, Donald Trump Jr., sits on the board of BlinkRx, a key business that may benefit financially from TrumpRx. Getting serious about medicine affordability means getting serious about challenging Big Pharma. For all Trump’s talk, Big Pharma is getting a lot of special favors from this White House, while patients still are waiting. Real drug price reform doesn’t look like a website."
Throughout his second White House term, Trump has made outlandish promises to cut drug costs and hosted top executives at the White House to tout splashy deals—only for pharmaceutical giants to continue jacking up prices. Reuters reported last month that drugmakers planned to "raise US prices on at least 350 branded medications, including vaccines against Covid, RSV, and shingles and blockbuster cancer treatment Ibrance" in 2026.
Merith Basey, CEO of Patients for Affordable Drugs Now, said in a statement that the Trump administration's "voluntary agreements" with drug companies "lack clear enforcement mechanisms and still put the power to set and increase prices firmly in the hands of pharmaceutical corporations."
"Patients in our community will soon learn if they can reliably access these discounts at the pharmacy counter, where the program will ultimately be tested and where affordability matters most," Basey said of TrumpRx.
Keep ReadingShow Less
Most Popular